RADIATION · Unmapped registry intervention
Moderate hypofractionated radiotherapy (Moderate-hypoRT)
Find medicine records ·
Find other trials using this name
Clinical trial
Salvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer
NCT07500701
Drugs and interventions used in this trial
2 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
RADIATION · Unmapped registry intervention
Ultra-hypofractionated radiotherapy (Ultra-hypoRT)
Find medicine records ·
Find other trials using this name
No matching interventions in this trial.
Study at a glance
Registry-backedSalvage Moderate Hypofractionated Versus Ultrahypofractionated Radiotherapy for Biochemical Recurrence After Radical Prostatectomy in Prostate Cancer
Design: INTERVENTIONAL · Status: RECRUITING · Phase: PHASE3
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Prostate Cancerverified · MONDO: prostate cancer
Interventions
Sponsors & collaborators
Samsung Medical Centerlead sponsor
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT07500701 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.